Effect of Kohlrabi on prevention of renal stone
Phase 2
- Conditions
- Renal stone.Calculus of kidney-Nephrolithiasis NOS-Renal calculus or stone-Staghorn calculus-Stone in kidney
- Registration Number
- IRCT2017021028003N2
- Lead Sponsor
- Ahwaz Jundishapour University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
1-Prehension of Informed consent for participation in the study
2-Subjects without special disease and disusing of any traditional or industrial drug.
3-Patients with history of recurrent renal stone: within the study and 6-8 weeks before initiation of it, ought not to use drug associated with decreasing recurrence of renal stone and/or superposed as instance of any urologic procedures such as TUL, PCNL & ESWL.
4-Disusing of warfarin drug and vitamin supplements in all groups.
5-Impassibility to Brassica oleracea in all groups.
Exclusion criteria:
1-Patient disinclination for continuance of participation in the study.
2-Incidenting of sensitivity or any adverse reaction to utilized drug.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rinary concentration of oxalate. Timepoint: 0 & 14th days of study. Method of measurement: 24-hour urine collection test.;Urinary concentration of calcium. Timepoint: 0 & 14th days of study. Method of measurement: 24-hour urine collection test.;Urinary concentration of uric acid. Timepoint: 0 & 14th days of study. Method of measurement: 24-hour urine collection test.;Urinary concentration of citrate. Timepoint: 0 & 14th days of study. Method of measurement: 24-hour urine collection test.;Urinary crystals. Timepoint: 0 & 14th days of study. Method of measurement: 24-hour urine collection test.
- Secondary Outcome Measures
Name Time Method Size of renal stone. Timepoint: 0 & 14th days of study. Method of measurement: Abdominopelvic CT scan without contrast.;Serum cratinine. Timepoint: 0 & 14th days of study. Method of measurement: Blood test.;BUN. Timepoint: 0 & 14th days of study. Method of measurement: Blood test.;ALT. Timepoint: 0 & 14th days of study. Method of measurement: Blood test.;AST. Timepoint: 0 & 14th days of study. Method of measurement: Blood test.;Serum calcium. Timepoint: 0 & 14th days of study. Method of measurement: Blood test.;Serum phosphore. Timepoint: 0 & 14th days of study. Method of measurement: Blood test.;Urine PH. Timepoint: 0 & 14th days of study. Method of measurement: Urine test.